Hercules Capital added five experienced professionals to its technology investment and credit teams, including Lee Merkle-Raymond, Charlie Vandis, Tom Harris, Michael Riffle and Anthony Riffle.
Sorrento Therapeutics, a clinical-stage biopharmaceutical company developing treatments for cancer and other diseases, entered into a loan and security agreement with Hercules Capital for up to $75 million.
Flowonix Medical obtained $15.5 million in financing that included $5 million in venture term debt financing with Hercules Capital.
FuelCell Energy closed a long-term loan facility with Hercules Capital, for up to $25 million to support the development of fuel cell projects.
Hercules Capital expanded its credit facility with Wells Fargo Capital Finance under which EverBank has committed $25 million, for a total of a $120 million in capacity under a $300 million accordion credit facility.